BRCA Genetic Testing Recommendation
You should use a validated familial risk assessment tool to determine if this patient meets criteria for genetic counseling referral, and only proceed with BRCA testing if her family history indicates increased risk for harmful BRCA mutations. 1, 2
Critical First Step: Risk Stratification
The USPSTF explicitly recommends against routine BRCA testing for women whose family history is not associated with increased risk for harmful BRCA1/2 mutations 1. The key question is whether having one relative with breast cancer constitutes sufficient risk.
Apply a Brief Risk Assessment Tool
You must use one of the validated screening tools to determine if she qualifies for genetic counseling 1:
- Family History Screen-7 (FHS-7) - simplest and quickest to administer
- Referral Screening Tool (B-RST) - also simple and quick
- Ontario Family History Assessment Tool
- Manchester Scoring System
- Pedigree Assessment Tool
Do NOT use general breast cancer risk tools like the Gail model - these are not designed to determine BRCA testing candidacy 1.
Key Family History Red Flags
The tools assess for high-risk features that indicate potential BRCA mutations 1:
- Breast cancer diagnosed before age 50
- Bilateral breast cancer
- Breast cancer plus ovarian cancer in the family
- Breast cancer in a male family member
- Multiple cases of breast cancer in the family
- Ovarian, tubal, or peritoneal cancer at any age
- Ashkenazi Jewish ancestry
Critical Detail Missing from Your Case
You need to know:
- Which relative (first-degree like mother/sister vs. second-degree like aunt/grandmother)
- Age at diagnosis of the affected relative
- Whether the relative had bilateral disease
- Whether any relatives had ovarian/tubal/peritoneal cancer
- Maternal AND paternal lineage history (BRCA mutations follow autosomal dominant pattern) 1
The Two-Pathway Algorithm
If Risk Assessment Tool is POSITIVE:
- Refer for genetic counseling (not direct testing) 1
- Genetic counselor performs detailed kindred analysis
- Ideally, test the affected relative first if available 1
- If no affected relative available, testing the unaffected patient is reasonable 1
- Ensure pre-test AND post-test counseling due to complexity of results 1
If Risk Assessment Tool is NEGATIVE:
Do not refer for genetic counseling or BRCA testing - the USPSTF gives this a D recommendation (recommends against) 2. For women without increased familial risk, benefits are "small to none" while harms are "small to moderate" 1.
Common Pitfall to Avoid
Having "a relative with breast cancer" alone is insufficient information. A single second-degree relative diagnosed at age 65 does NOT warrant testing, while a first-degree relative diagnosed at age 35 clearly does. The specifics matter critically 1.
Practical Reality Check
In general U.S. populations, only 0.2-0.3% of women carry BRCA mutations 1. Testing low-risk women leads to:
- False reassurance from uninformative-negative results
- Anxiety from variants of uncertain significance
- Unnecessary interventions
- Healthcare system burden
Studies show that even among women who screen positive on FHS-7, only 9.5% actually discuss genetic testing with providers and only 2.7% complete testing 3, suggesting real-world implementation challenges.
Bottom Line for This Patient
Obtain the complete family history details specified above, apply a validated risk assessment tool (FHS-7 or B-RST recommended for efficiency), and only refer for genetic counseling if the tool indicates increased risk. 1, 2 If she screens negative, reassure her that routine BRCA testing is not recommended and would likely cause more harm than benefit.